英国在丙肝防控方面取得显著进展，正成为全球首批实现丙肝消除的国家之一。[1]该国已达成治疗80%已知病例的目标，这一成就得到了显著的死亡率改善所印证——过去十年内，丙肝相关死亡率下降了36%。[1]自2015年起，超过10万人在英国被诊断并接受了丙肝治疗。[1]
在诊断覆盖方面，英国已诊断丙肝患者占84.6%，接近世界卫生组织90%的诊断目标。[1]当前英国约有50,200名成年人患有丙肝。[1]现代抗病毒药物具有高度有效性，能在8至12周内治愈95%以上的病例。[1]根据世界卫生组织设定的2030年消除目标，英国目前的进展表明该国有望按时达成这一公共卫生里程碑。[1]
England is positioning itself as one of the world's leading nations in eliminating hepatitis C, having achieved major milestones in diagnosis and treatment. The country has met its target of treating 80% of known hepatitis C cases, while hepatitis C-related deaths have declined by 36% over the past decade [1]. Since 2015, more than 100,000 people have been diagnosed and treated for the virus, bringing the diagnostic rate to 84.6%—approaching the 90% target [1]. With antiviral medications capable of curing over 95% of cases within 8 to 12 weeks of treatment, England's progress demonstrates the feasibility of achieving World Health Organization elimination goals by 2030 [1].
Current epidemiological data shows approximately 50,200 adults living with hepatitis C in England as of 2024 [1]. Public health authorities have identified priority populations requiring testing, including adults born in countries with higher hepatitis C prevalence such as Ukraine, Romania, and Estonia [1]. The combination of effective treatment availability and systematic diagnostic expansion has enabled the nation to substantially reduce both disease burden and mortality.